ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,100.90
0.08%
S&P 500
5,214.08
0.51%
Dow Jones
39,387.76
0.85%
US Dollar vs Yen
155.747
0.23%
Brent Oil
84.085
0.16%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. ヨーロッパ
  5. EU
  6. Crossject (ALCJ)

  7. Crossject (ALCJ) ニュース

ALCJ

Crossject (ALCJ)

Crossject
から:
次の項目別のソート:
 Showing the most relevant articles for your search:EU:ALCJ
日付受信時刻ニュースソース見出しコード企業名
2024/05/0300 : 30GlobeNewswire Inc.Crossject signs a geographic extension of ZEPIZURE® commercialization agreement in EuropeEU:ALCJCrossject
2024/05/0300 : 30GlobeNewswire Inc.Crossject signe une extension géographique de l'accord de commercialisation de ZEPIZURE® en EuropeEU:ALCJCrossject
2024/05/0300 : 30GlobeNewswire Inc.Crossject signs a geographic extension of ZEPIZURE® commercialization agreement in EuropeEU:ALCJCrossject
2024/05/0102 : 05GlobeNewswire Inc.Crossject annonce le lancement d’une augmentation de capitalEU:ALCJCrossject
2024/04/2514 : 32GlobeNewswire Inc.Crossject reports audited financial results for 2023EU:ALCJCrossject
2024/04/2514 : 32GlobeNewswire Inc.Crossject reports audited financial results for 2023EU:ALCJCrossject
2024/04/2514 : 32GlobeNewswire Inc.Crossject communique ses résultats financiers audités pour 2023EU:ALCJCrossject
2024/04/1023 : 30GlobeNewswire Inc.Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital socialEU:ALCJCrossject
2024/04/0301 : 35GlobeNewswire Inc.Crossject trading on Euronext to resume as usual on Wednesday April 3EU:ALCJCrossject
2024/04/0301 : 35GlobeNewswire Inc.La cotation sur l’action de Crossject à Euronext reprendra comme d’habitude le mercredi 3 avrilEU:ALCJCrossject
2024/04/0217 : 30GlobeNewswire Inc.Crossject advances in its U.S. Strategy and reports Financial Results for 2023EU:ALCJCrossject
2024/04/0217 : 30GlobeNewswire Inc.Crossject advances in its U.S. Strategy and reports Financial Results for 2023EU:ALCJCrossject
2024/04/0217 : 30GlobeNewswire Inc.Crossject poursuit sa stratégie de développement aux États-Unis et publie ses résultats financiers pour 2023EU:ALCJCrossject
2024/03/0815 : 30GlobeNewswire Inc.Crossject gender equality score reaches 96/100 in 2024EU:ALCJCrossject
2024/03/0815 : 30GlobeNewswire Inc.Le Score de l’index Egalité femmes-hommes chez Crossject atteint 96/100 en 2024EU:ALCJCrossject
2024/03/0815 : 30GlobeNewswire Inc.Crossject gender equality score reaches 96/100 in 2024EU:ALCJCrossject
2024/02/2716 : 30GlobeNewswire Inc.Crossject obtains a financing up to €12 million, in two tranchesEU:ALCJCrossject
2024/02/2716 : 30GlobeNewswire Inc.Crossject obtains a financing up to €12 million, in two tranchesEU:ALCJCrossject
2024/02/2716 : 30GlobeNewswire Inc.Crossject obtient un financement jusqu’à 12 millions d’euros en 2 tranchesEU:ALCJCrossject
2024/02/0701 : 30GlobeNewswire Inc.Crossject publie une mise à jour stratégique de ses priorités pour 2024EU:ALCJCrossject
2024/02/0701 : 30GlobeNewswire Inc.Crossject provides strategic update on priorities for 2024EU:ALCJCrossject
2024/02/0701 : 30GlobeNewswire Inc.Crossject provides strategic update on priorities for 2024EU:ALCJCrossject
2024/02/0202 : 15GlobeNewswire Inc.Crossject to host a business briefing on commercial strategy on February 6 at 17:30 CETEU:ALCJCrossject
2024/02/0202 : 15GlobeNewswire Inc.Crossject organisera un webcast le 6 février à 17h30 pour faire le point sur sa stratégie commercialeEU:ALCJCrossject
2024/02/0202 : 15GlobeNewswire Inc.Crossject to host a business briefing on commercial strategy on February 6 at 17:30 CETEU:ALCJCrossject
2024/01/1701 : 15GlobeNewswire Inc.Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital socialEU:ALCJCrossject
2024/01/1000 : 21GlobeNewswire Inc.Crossject to present at Biotech Showcase on January 9 at 16:30 PTEU:ALCJCrossject
2024/01/1000 : 21GlobeNewswire Inc.Crossject annonce l’initiation de la couverture de son titre par ODDO BHFEU:ALCJCrossject
2024/01/1000 : 21GlobeNewswire Inc.Crossject to present at Biotech Showcase on January 9 at 16:30 PTEU:ALCJCrossject
2024/01/0502 : 00GlobeNewswire Inc.Crossject engage Syneos Health pour le lancement commercial du ZEPIZURE® aux États-UnisEU:ALCJCrossject
 Showing the most relevant articles for your search:EU:ALCJ

最近閲覧した銘柄

PM
XAUUSD
Gold vs US Dollar
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
JPM
JP Morgan Chase
NYSE
AXP
American Express
NASDAQ
NVDA
NVIDIA
NYSE
NKE
Nike
USOTC
BNPQY
BNP Paribas (QX)
FX
USDGBP
US Dollar vs Sterling
CCOM
US500
US 500
NYSE
DIS
Walt Disney
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
CVX
Chevron
COIN
SOLUSD
Solana
NYSE
KO
Coca Cola
COIN
BTCUSD
Bitcoin
NYSE
BAC
Bank of America
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有